Cancer Research Targets  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 4079, May 1, 2007. doi: 10.1158/0008-5472.CAN-06-4025
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, H.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, H.
Right arrow Articles by Mori, H.

Molecular Biology, Pathobiology, and Genetics

Development of Gastric Tumors in ApcMin/+ Mice by the Activation of the ß-Catenin/Tcf Signaling Pathway

Hiroyuki Tomita1,2, Yasuhiro Yamada1, Takeru Oyama1, Kazuya Hata1, Yoshinobu Hirose1, Akira Hara1, Takahiro Kunisada3, Yasuyuki Sugiyama2, Yosuke Adachi2, Heinz Linhart4 and Hideki Mori1

Departments of 1 Tumor Pathology, 2 Oncologic Surgery, and 3 Tissue and Organ Development, Gifu University Graduate School of Medicine, Gifu, Japan and 4 Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts

Requests for reprints: Yasuhiro Yamada, Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. Phone: 81-58-230-6225; Fax: 81-58-230-6226; E-mail: y-yamada{at}gifu-u.ac.jp.

Although several lines of evidence suggest the involvement of the Wnt pathway in the development of gastric cancers, the functional significance of the pathway in gastric carcinogenesis is still poorly defined. To examine the role of the Apc/ß-catenin signaling pathway in the development of gastric cancers, we investigated the gastric mucosa of the ApcMin/+ mouse, which is a murine model for familial adenomatous polyposis, carrying a germ-line mutation at codon 850 of Apc. We found that aged ApcMin/+ mice spontaneously develop multiple tumors in the stomach, which are accompanied by loss of heterozygosity of Apc. Such tumors consisted of adenomatous glands with strong nuclear accumulation of ß-catenin. Even a single adenomatous gland already showed nuclear accumulation of ß-catenin, suggesting that Apc/ß-catenin pathway is an initiating event in gastric tumorigenesis in ApcMin/+ mice. Myc and cyclin D1 expressions, which are transcriptional targets of ß-catenin/Tcf, increased in the adenomatous lesions. Furthermore, ß-catenin/Tcf reporter transgenic mice with ApcMin allele showed higher levels of the transcriptional activity of ß-catenin/Tcf in the gastric tumors. We also treated ApcMin/+ and wild-type mice with N-methyl-N-nitrosourea (MNU), an alkylating agent that induces adenomas and adenocarcinomas in the stomach. Consequently, MNU-treated ApcMin/+ mice significantly enhanced the tumor development in comparison with ApcMin/+ mice or MNU-treated wild-type mice. Several gastric tumors in MNU-treated ApcMin/+ mice showed invasion into the submucosal layer. These results indicate that the Apc/ß-catenin pathway may play an important role in at least subset of gastric carcinomas. In addition, ApcMin/+ mice combined with MNU could be a useful short-term model to investigate multistage carcinogenesis in the stomach. [Cancer Res 2007;67(9):4079–87]




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Humar, V. Blair, A. Charlton, H. More, I. Martin, and P. Guilford
E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
Cancer Res., March 1, 2009; 69(5): 2050 - 2056.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Guo, J. Xie, E. Rubin, Y.-X. Tang, F. Lin, X. Zi, and B. H. Hoang
Frzb, a Secreted Wnt Antagonist, Decreases Growth and Invasiveness of Fibrosarcoma Cells Associated with Inhibition of Met Signaling
Cancer Res., May 1, 2008; 68(9): 3350 - 3360.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Oyama, Y. Yamada, K. Hata, H. Tomita, A. Hirata, H. Sheng, A. Hara, H. Aoki, T. Kunisada, S. Yamashita, et al.
Further upregulation of {beta}-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice
Carcinogenesis, March 1, 2008; 29(3): 666 - 672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.